BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 20579536)

  • 1. The long and winding road to warfarin pharmacogenetic testing.
    Ginsburg GS; Voora D
    J Am Coll Cardiol; 2010 Jun; 55(25):2813-5. PubMed ID: 20579536
    [No Abstract]   [Full Text] [Related]  

  • 2. Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness study).
    Epstein RS; Moyer TP; Aubert RE; O Kane DJ; Xia F; Verbrugge RR; Gage BF; Teagarden JR
    J Am Coll Cardiol; 2010 Jun; 55(25):2804-12. PubMed ID: 20381283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathology consultation on warfarin pharmacogenetic testing.
    Stack G;
    Am J Clin Pathol; 2011 Jan; 135(1):13-9. PubMed ID: 21173120
    [No Abstract]   [Full Text] [Related]  

  • 4. Refining the use of warfarin through genetic testing.
    Lee SC
    Int Angiol; 2008 Aug; 27(4):271-3. PubMed ID: 18677287
    [No Abstract]   [Full Text] [Related]  

  • 5. Using genetic testing to guide warfarin therapy.
    Ungerer LL; Pestka EL; Messner PK
    Nursing; 2012 May; 42(5):63-5. PubMed ID: 22531080
    [No Abstract]   [Full Text] [Related]  

  • 6. Dynamic pharmacogenetic models in anticoagulation therapy.
    Bon Homme M; Reynolds KK; Valdes R; Linder MW
    Clin Lab Med; 2008 Dec; 28(4):539-52. PubMed ID: 19059061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulant therapy: warfarin sensitivity genotyping closer to clinical practice.
    van der Zee SA; Halperin JL
    Nat Rev Cardiol; 2010 Oct; 7(10):549-50. PubMed ID: 20865027
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacogenomic testing for warfarin dosing: we are ready now.
    Wu AH
    Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1483-5. PubMed ID: 19954308
    [No Abstract]   [Full Text] [Related]  

  • 9. Warfarin and pharmacogenomic testing: what would Pascal do?
    Teagarden JR
    Pharmacotherapy; 2009 Mar; 29(3):245-7. PubMed ID: 19249943
    [No Abstract]   [Full Text] [Related]  

  • 10. Prediction of warfarin dose: why, when and how?
    Eriksson N; Wadelius M
    Pharmacogenomics; 2012 Mar; 13(4):429-40. PubMed ID: 22379999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetic-based dosing of warfarin.
    Med Lett Drugs Ther; 2008 May; 50(1286):39-40. PubMed ID: 18487958
    [No Abstract]   [Full Text] [Related]  

  • 12. An analysis of the relative effects of VKORC1 and CYP2C9 variants on anticoagulation related outcomes in warfarin-treated patients.
    Meckley LM; Wittkowsky AK; Rieder MJ; Rettie AE; Veenstra DL
    Thromb Haemost; 2008 Aug; 100(2):229-39. PubMed ID: 18690342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic testing for warfarin dosing? Not yet ready for prime time.
    Bussey HI; Wittkowsky AK; Hylek EM; Walker MB
    Pharmacotherapy; 2008 Feb; 28(2):141-3. PubMed ID: 18225960
    [No Abstract]   [Full Text] [Related]  

  • 14. Warfarin dose requirement for patients with both VKORC1 3673A/A and CYP2C9*3/*3 genotypes.
    Fukuda T; Tanabe T; Ohno M; Tougou K; Fujio Y; Azuma J; Yamamoto I; Takeda A
    Clin Pharmacol Ther; 2006 Nov; 80(5):553-4. PubMed ID: 17112813
    [No Abstract]   [Full Text] [Related]  

  • 15. Understanding the pharmacogenetic approach to warfarin dosing.
    Glurich I; Burmester JK; Caldwell MD
    Heart Fail Rev; 2010 May; 15(3):239-48. PubMed ID: 18998206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomic considerations for customizing warfarin therapy in the orthopedic patient.
    Rhee S; Walsh K; Lewis D; Davis G; Smith KM
    Orthopedics; 2010 Nov; 33(11):828. PubMed ID: 21053849
    [No Abstract]   [Full Text] [Related]  

  • 17. Dosing anticoagulant therapy with coumarin drugs: is genotyping clinically useful? No.
    Mannucci PM; Spreafico M; Peyvandi F
    J Thromb Haemost; 2008 Sep; 6(9):1450-2. PubMed ID: 18627441
    [No Abstract]   [Full Text] [Related]  

  • 18. [Application of warfarin pharmacogenetics].
    Tomek A; Mat'oska V; Kumstýrfová T; Táborský L
    Vnitr Lek; 2009 Jun; 55(6):565-9. PubMed ID: 19662888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using pharmacogenetics in real time to guide warfarin initiation: a clinician update.
    Carlquist JF; Anderson JL
    Circulation; 2011 Dec; 124(23):2554-9. PubMed ID: 22144632
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacogenetics of warfarin: current status and future challenges.
    Wadelius M; Pirmohamed M
    Pharmacogenomics J; 2007 Apr; 7(2):99-111. PubMed ID: 16983400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.